황인규 프로필 사진

황인규

Hwang, In Gyu

의과대학

의학부(임상-서울)

Scopus ORCID

연구분야

  • 보건정책, 보건행정, 병원관리, 
  • 의학교육, 임상역학, 
  • 폐암, 위암 담도암, 빈혈

자료 필터

자료유형

발행연도

2006 ~ 2026
2006 2026

키워드

언어

전체 166건 중 31번부터 40번까지의 결과를 표시합니다.

2023
Article

Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia

  • Arai, Hidenori ; 
  • Maeda, Keisuke ; 
  • Wakabayashi, Hidetaka ; 
  • Naito, Tateaki ; 
  • Konishi, Masaaki ; 
  • ... Hwang, In Gyu ; 
  • 외 33명
  • 2023-09
  • Journal of Cachexia, Sarcopenia and Muscle
  • John Wiley and Sons Inc
Article

Comprehensive geriatric assessment based multidisciplinary team intervention for hospitalized frail patients in oncology: COMPASS-ONCO/KCSG AL21-13

  • Lee, Yun-Gyoo ; 
  • Hwang, In Gyu ; 
  • Koh, Su-Jin ; 
  • Hong, Soojung ; 
  • Kim, Jin Won ; 
  • 외 1명
  • 2023-06
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
2022
Article

COMPrehensive geriatric AsseSSment and multidisciplinary team intervention for hospitalised older adults (COMPASS): a protocol of pragmatic trials within a cohort

  • Choi, J.-Y. ; 
  • Lee, J.Y. ; 
  • Shin, J. ; 
  • Kim, C.O. ; 
  • Kim, K.J. ; 
  • ... Hwang, I.G. ; 
  • 외 8명
  • 2022-08
  • BMJ Open
  • NLM (Medline)
Article

The first report of K-Umbrella Gastric Cancer Study: An open label, multi-center, randomized, biomarker-integrated trial for second-line treatment of advanced gastric cancer (AGC).

  • Rha, Sun Young ; 
  • Lee, Choong-Kun ; 
  • Kim, Hyo Song ; 
  • Jung, Minkyu ; 
  • Kim, Hyunki ; 
  • ... Hwang, In Gyu ; 
  • 외 9명
  • 2022-06
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

A phase II study of chemotherapy in combination with telomerase peptide vaccine (GV1001) as second-line treatment in patients with metastatic colorectal cancer

  • Kim, Sejin ; 
  • Kim, Bum Jun ; 
  • Kim, Ilhwan ; 
  • Kim, Jung Han ; 
  • Kim, Hee Kyung ; 
  • ... Hwang, In Gyu ; 
  • ... Kwon, Jung Hye ; 
  • 외 6명
  • 2022-02
  • Journal of Cancer
  • IVYSPRING INT PUBL
Article

Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer

  • 2022-02
  • Journal of Cancer
  • Ivyspring International Publisher